HEADER TRANSFERASE 07-DEC-21 7QG2 TITLE IRAK4 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE KINASE DOMAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE INHIBITOR INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 KEYWDS 2 INTERLEUKIN-1 SIGNALING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,A.AAGAARD,G.R.ROBB,S.L.DEGORCE REVDAT 2 31-JAN-24 7QG2 1 REMARK REVDAT 1 04-MAY-22 7QG2 0 JRNL AUTH I.A.CUMMING,S.L.DEGORCE,A.AAGAARD,E.L.BRAYBROOKE,N.L.DAVIES, JRNL AUTH 2 C.R.DIENE,A.J.EATHERTON,H.R.FELSTEAD,S.D.GROOMBRIDGE, JRNL AUTH 3 E.M.LENZ,Y.LI,Y.NAI,S.PEARSON,G.R.ROBB,J.S.SCOTT, JRNL AUTH 4 O.R.STEWARD,C.WU,Y.XUE,L.ZHANG,Y.ZHANG JRNL TITL IDENTIFICATION AND OPTIMISATION OF A PYRIMIDOPYRIDONE SERIES JRNL TITL 2 OF IRAK4 INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 63 16729 2022 JRNL REFN ESSN 1464-3391 JRNL PMID 35439688 JRNL DOI 10.1016/J.BMC.2022.116729 REMARK 2 REMARK 2 RESOLUTION. 3.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 72.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 26624 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1312 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.03 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.05 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3029 REMARK 3 BIN FREE R VALUE : 0.3238 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 40 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8856 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 115 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.81190 REMARK 3 B22 (A**2) : 10.05680 REMARK 3 B33 (A**2) : -5.24500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.37520 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.420 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.472 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.916 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 9145 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 12356 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3242 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1567 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 9145 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1177 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7489 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.68 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.54 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -37.3434 14.6443 5.8277 REMARK 3 T TENSOR REMARK 3 T11: 0.0586 T22: -0.1084 REMARK 3 T33: -0.0613 T12: 0.0211 REMARK 3 T13: 0.162 T23: -0.0445 REMARK 3 L TENSOR REMARK 3 L11: 1.3542 L22: 2.2945 REMARK 3 L33: 1.9247 L12: -0.9403 REMARK 3 L13: 0.0855 L23: -0.1342 REMARK 3 S TENSOR REMARK 3 S11: -0.0285 S12: 0.1857 S13: -0.206 REMARK 3 S21: 0.1857 S22: 0.1109 S23: 0.021 REMARK 3 S31: -0.206 S32: 0.021 S33: -0.0823 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -6.486 -15.0525 -39.557 REMARK 3 T TENSOR REMARK 3 T11: 0.0033 T22: -0.1246 REMARK 3 T33: 0.0163 T12: 0.0384 REMARK 3 T13: 0.1896 T23: 0.0029 REMARK 3 L TENSOR REMARK 3 L11: 1.6305 L22: 1.8324 REMARK 3 L33: 2.236 L12: 0.3187 REMARK 3 L13: -0.3294 L23: 0.1253 REMARK 3 S TENSOR REMARK 3 S11: 0.0532 S12: -0.2326 S13: -0.0533 REMARK 3 S21: -0.2326 S22: -0.1555 S23: 0.2949 REMARK 3 S31: -0.0533 S32: 0.2949 S33: 0.1023 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { C|* } REMARK 3 ORIGIN FOR THE GROUP (A): -33.7795 -15.9764 -11.3566 REMARK 3 T TENSOR REMARK 3 T11: 0.095 T22: -0.2012 REMARK 3 T33: -0.0055 T12: -0.0058 REMARK 3 T13: 0.1862 T23: 0.0451 REMARK 3 L TENSOR REMARK 3 L11: 1.8087 L22: 2.5905 REMARK 3 L33: 1.39 L12: -0.6667 REMARK 3 L13: 0.4178 L23: -1.1978 REMARK 3 S TENSOR REMARK 3 S11: -0.1958 S12: -0.1049 S13: 0.1045 REMARK 3 S21: -0.1049 S22: 0.165 S23: -0.0891 REMARK 3 S31: 0.1045 S32: -0.0891 S33: 0.0308 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { D|* } REMARK 3 ORIGIN FOR THE GROUP (A): -19.6998 15.853 -29.6154 REMARK 3 T TENSOR REMARK 3 T11: 0.0945 T22: -0.2083 REMARK 3 T33: 0.0178 T12: -0.0177 REMARK 3 T13: 0.221 T23: -0.0048 REMARK 3 L TENSOR REMARK 3 L11: 1.2585 L22: 1.437 REMARK 3 L33: 2.395 L12: 0.8285 REMARK 3 L13: 0.3009 L23: 0.1771 REMARK 3 S TENSOR REMARK 3 S11: 0.1161 S12: -0.0353 S13: -0.2727 REMARK 3 S21: -0.0353 S22: 0.1186 S23: 0.187 REMARK 3 S31: -0.2727 S32: 0.187 S33: -0.2347 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: NULL REMARK 3 ORIGIN FOR THE GROUP (A): -24.3611 -0.2462 -18.8304 REMARK 3 T TENSOR REMARK 3 T11: 0.0301 T22: 0.048 REMARK 3 T33: 0.1551 T12: -0.1244 REMARK 3 T13: 0.046 T23: 0.0931 REMARK 3 L TENSOR REMARK 3 L11: -0.1317 L22: 0.1419 REMARK 3 L33: 0.3714 L12: -1.1219 REMARK 3 L13: -0.0244 L23: -0.1192 REMARK 3 S TENSOR REMARK 3 S11: 0.0633 S12: -0.118 S13: -0.0876 REMARK 3 S21: -0.118 S22: 0.3133 S23: -0.0337 REMARK 3 S31: -0.0876 S32: -0.0337 S33: -0.3766 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7QG2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1292119525. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JAN-17 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.966 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26624 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.030 REMARK 200 RESOLUTION RANGE LOW (A) : 72.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.48600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6RFJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5 M AMS, 0.1 M HEPES PH 7.67, REMARK 280 EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 70.69500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 69.86000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 70.69500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 69.86000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 153 REMARK 465 GLU A 154 REMARK 465 ASN A 155 REMARK 465 LYS A 156 REMARK 465 SER A 157 REMARK 465 LEU A 158 REMARK 465 GLU A 159 REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 THR A 163 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 THR A 222 REMARK 465 THR A 223 REMARK 465 GLU A 224 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 THR A 342 REMARK 465 ALA A 459 REMARK 465 SER A 460 REMARK 465 GLY B 153 REMARK 465 GLU B 154 REMARK 465 ASN B 155 REMARK 465 LYS B 156 REMARK 465 SER B 157 REMARK 465 LEU B 158 REMARK 465 GLU B 159 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 ARG B 164 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 THR B 222 REMARK 465 THR B 223 REMARK 465 GLU B 224 REMARK 465 GLU B 225 REMARK 465 GLY B 255 REMARK 465 ASP B 256 REMARK 465 ALA B 335 REMARK 465 SER B 336 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 THR B 342 REMARK 465 ALA B 459 REMARK 465 SER B 460 REMARK 465 GLY C 153 REMARK 465 GLU C 154 REMARK 465 ASN C 155 REMARK 465 LYS C 156 REMARK 465 SER C 157 REMARK 465 LEU C 158 REMARK 465 GLU C 159 REMARK 465 VAL C 160 REMARK 465 SER C 161 REMARK 465 ASP C 162 REMARK 465 THR C 163 REMARK 465 ALA C 217 REMARK 465 MET C 218 REMARK 465 VAL C 219 REMARK 465 ASP C 220 REMARK 465 SER C 336 REMARK 465 GLU C 337 REMARK 465 LYS C 338 REMARK 465 PHE C 339 REMARK 465 ALA C 340 REMARK 465 GLN C 341 REMARK 465 THR C 342 REMARK 465 ALA C 459 REMARK 465 SER C 460 REMARK 465 GLY D 153 REMARK 465 GLU D 154 REMARK 465 ASN D 155 REMARK 465 LYS D 156 REMARK 465 SER D 157 REMARK 465 LEU D 158 REMARK 465 GLU D 159 REMARK 465 VAL D 160 REMARK 465 SER D 161 REMARK 465 ASP D 162 REMARK 465 THR D 163 REMARK 465 ALA D 217 REMARK 465 MET D 218 REMARK 465 VAL D 219 REMARK 465 ASP D 220 REMARK 465 ILE D 221 REMARK 465 THR D 222 REMARK 465 THR D 223 REMARK 465 GLU D 224 REMARK 465 SER D 336 REMARK 465 GLU D 337 REMARK 465 LYS D 338 REMARK 465 PHE D 339 REMARK 465 ALA D 340 REMARK 465 GLN D 341 REMARK 465 THR D 342 REMARK 465 ALA D 459 REMARK 465 SER D 460 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 253 55.05 -145.83 REMARK 500 ARG A 310 -3.25 75.86 REMARK 500 ASP A 311 48.41 -147.99 REMARK 500 ASP A 329 81.60 61.14 REMARK 500 HIS A 390 48.43 -103.95 REMARK 500 LYS A 417 31.74 -85.16 REMARK 500 PHE B 197 50.30 -118.06 REMARK 500 ASN B 206 20.60 80.79 REMARK 500 ASN B 207 -3.50 71.95 REMARK 500 SER B 253 50.74 -149.43 REMARK 500 ARG B 310 -4.26 76.59 REMARK 500 ASP B 311 49.06 -148.33 REMARK 500 ASP B 329 88.47 55.73 REMARK 500 HIS B 390 50.15 -103.40 REMARK 500 LYS B 417 31.72 -86.54 REMARK 500 ASP C 181 109.48 -59.99 REMARK 500 PHE C 197 -53.38 -129.99 REMARK 500 ASN C 206 -122.20 72.97 REMARK 500 ASP C 257 81.27 129.27 REMARK 500 ARG C 310 -2.70 75.35 REMARK 500 ASP C 311 48.33 -148.69 REMARK 500 ASP C 320 -165.69 -78.97 REMARK 500 ASP C 329 95.37 55.60 REMARK 500 HIS C 390 48.15 -102.99 REMARK 500 LYS C 417 32.95 -86.79 REMARK 500 ARG D 310 -5.16 76.38 REMARK 500 ASP D 311 48.59 -147.26 REMARK 500 ASP D 329 94.84 57.48 REMARK 500 HIS D 390 50.02 -104.72 REMARK 500 LYS D 417 32.96 -85.93 REMARK 500 REMARK 500 REMARK: NULL DBREF 7QG2 A 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 DBREF 7QG2 B 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 DBREF 7QG2 C 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 DBREF 7QG2 D 154 460 UNP Q9NWZ3 IRAK4_HUMAN 30 336 SEQADV 7QG2 GLY A 153 UNP Q9NWZ3 EXPRESSION TAG SEQADV 7QG2 GLY B 153 UNP Q9NWZ3 EXPRESSION TAG SEQADV 7QG2 GLY C 153 UNP Q9NWZ3 EXPRESSION TAG SEQADV 7QG2 GLY D 153 UNP Q9NWZ3 EXPRESSION TAG SEQRES 1 A 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 A 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 A 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 A 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 A 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 A 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 A 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 A 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 A 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 A 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 A 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 A 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 A 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 A 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 A 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP ARG SEQRES 16 A 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 A 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 A 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 A 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 A 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 A 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 A 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 A 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 A 308 GLN LEU LEU GLN GLU MET THR ALA SER SEQRES 1 B 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 B 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 B 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 B 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 B 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 B 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 B 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 B 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 B 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 B 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 B 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 B 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 B 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 B 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 B 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP ARG SEQRES 16 B 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 B 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 B 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 B 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 B 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 B 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 B 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 B 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 B 308 GLN LEU LEU GLN GLU MET THR ALA SER SEQRES 1 C 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 C 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 C 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 C 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 C 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 C 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 C 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 C 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 C 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 C 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 C 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 C 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 C 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 C 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 C 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP ARG SEQRES 16 C 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 C 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 C 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 C 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 C 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 C 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 C 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 C 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 C 308 GLN LEU LEU GLN GLU MET THR ALA SER SEQRES 1 D 308 GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE SEQRES 2 D 308 HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN SEQRES 3 D 308 ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS SEQRES 4 D 308 MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR SEQRES 5 D 308 VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA SEQRES 6 D 308 MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE SEQRES 7 D 308 ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU SEQRES 8 D 308 ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP SEQRES 9 D 308 ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER SEQRES 10 D 308 LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO SEQRES 11 D 308 LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA SEQRES 12 D 308 ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE SEQRES 13 D 308 HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU SEQRES 14 D 308 ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG SEQRES 15 D 308 ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP ARG SEQRES 16 D 308 ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU SEQRES 17 D 308 ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE SEQRES 18 D 308 GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA SEQRES 19 D 308 VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE SEQRES 20 D 308 LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP SEQRES 21 D 308 TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER SEQRES 22 D 308 VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS SEQRES 23 D 308 GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN SEQRES 24 D 308 GLN LEU LEU GLN GLU MET THR ALA SER MODRES 7QG2 TPO A 345 THR MODIFIED RESIDUE MODRES 7QG2 SEP A 346 SER MODIFIED RESIDUE MODRES 7QG2 TPO B 345 THR MODIFIED RESIDUE MODRES 7QG2 SEP B 346 SER MODIFIED RESIDUE MODRES 7QG2 TPO C 345 THR MODIFIED RESIDUE MODRES 7QG2 SEP C 346 SER MODIFIED RESIDUE MODRES 7QG2 TPO D 345 THR MODIFIED RESIDUE MODRES 7QG2 SEP D 346 SER MODIFIED RESIDUE HET TPO A 345 11 HET SEP A 346 10 HET TPO B 345 11 HET SEP B 346 10 HET TPO C 345 11 HET SEP C 346 10 HET TPO D 345 11 HET SEP D 346 10 HET B6I A 501 30 HET B6I B 501 30 HET B6I C 501 30 HET B6I D 501 30 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM B6I 6-METHYL-4-[(1-METHYLCYCLOPROPYL)AMINO]-2-[[1-(1- HETNAM 2 B6I METHYLPIPERIDIN-4-YL)PYRAZOL-4-YL]AMINO]PYRIDO[4,3- HETNAM 3 B6I D]PYRIMIDIN-5-ONE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 4(C4 H10 N O6 P) FORMUL 1 SEP 4(C3 H8 N O6 P) FORMUL 5 B6I 4(C21 H28 N8 O) FORMUL 9 HOH *115(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 PRO A 184 GLY A 188 5 5 HELIX 3 AA3 LEU A 226 CYS A 240 1 15 HELIX 4 AA4 SER A 269 SER A 275 1 7 HELIX 5 AA5 CYS A 276 THR A 280 5 5 HELIX 6 AA6 SER A 284 ASN A 305 1 22 HELIX 7 AA7 LYS A 313 ALA A 315 5 3 HELIX 8 AA8 ALA A 356 ARG A 361 1 6 HELIX 9 AA9 THR A 365 GLY A 383 1 19 HELIX 10 AB1 LEU A 395 LEU A 397 5 3 HELIX 11 AB2 ASP A 398 ASP A 405 1 8 HELIX 12 AB3 THR A 409 ILE A 414 1 6 HELIX 13 AB4 ASP A 422 LEU A 437 1 16 HELIX 14 AB5 LYS A 440 ARG A 444 5 5 HELIX 15 AB6 ASP A 446 MET A 457 1 12 HELIX 16 AB7 SER B 169 THR B 177 1 9 HELIX 17 AB8 PRO B 184 GLY B 188 5 5 HELIX 18 AB9 LYS B 227 CYS B 240 1 14 HELIX 19 AC1 SER B 269 SER B 275 1 7 HELIX 20 AC2 CYS B 276 THR B 280 5 5 HELIX 21 AC3 SER B 284 ASN B 305 1 22 HELIX 22 AC4 LYS B 313 ALA B 315 5 3 HELIX 23 AC5 ALA B 356 ARG B 361 1 6 HELIX 24 AC6 THR B 365 GLY B 383 1 19 HELIX 25 AC7 LEU B 395 LEU B 397 5 3 HELIX 26 AC8 ASP B 398 ASP B 405 1 8 HELIX 27 AC9 THR B 409 ILE B 414 1 6 HELIX 28 AD1 ASP B 422 LEU B 437 1 16 HELIX 29 AD2 ASP B 446 MET B 457 1 12 HELIX 30 AD3 SER C 169 THR C 177 1 9 HELIX 31 AD4 THR C 222 CYS C 240 1 19 HELIX 32 AD5 SER C 269 SER C 275 1 7 HELIX 33 AD6 CYS C 276 THR C 280 5 5 HELIX 34 AD7 SER C 284 ASN C 305 1 22 HELIX 35 AD8 LYS C 313 ALA C 315 5 3 HELIX 36 AD9 ALA C 356 ARG C 361 1 6 HELIX 37 AE1 THR C 365 GLY C 383 1 19 HELIX 38 AE2 LEU C 397 ASP C 405 1 9 HELIX 39 AE3 THR C 409 ILE C 414 1 6 HELIX 40 AE4 ASP C 422 LEU C 437 1 16 HELIX 41 AE5 LYS C 440 ARG C 444 5 5 HELIX 42 AE6 ASP C 446 MET C 457 1 12 HELIX 43 AE7 SER D 169 THR D 177 1 9 HELIX 44 AE8 PRO D 184 GLY D 188 5 5 HELIX 45 AE9 LEU D 226 CYS D 240 1 15 HELIX 46 AF1 SER D 269 SER D 275 1 7 HELIX 47 AF2 CYS D 276 THR D 280 5 5 HELIX 48 AF3 SER D 284 ASN D 305 1 22 HELIX 49 AF4 LYS D 313 ALA D 315 5 3 HELIX 50 AF5 ALA D 356 ARG D 361 1 6 HELIX 51 AF6 THR D 365 GLY D 383 1 19 HELIX 52 AF7 LEU D 395 LEU D 397 5 3 HELIX 53 AF8 ASP D 398 ASP D 405 1 8 HELIX 54 AF9 THR D 409 ILE D 414 1 6 HELIX 55 AG1 ASP D 422 LEU D 437 1 16 HELIX 56 AG2 LYS D 440 ARG D 444 5 5 HELIX 57 AG3 ASP D 446 MET D 457 1 12 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 SER A 252 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N GLY A 250 SHEET 4 AA1 6 THR A 209 LEU A 215 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 GLY A 198 TYR A 204 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLY A 195 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 HIS A 307 ILE A 308 0 SHEET 2 AA2 2 ARG A 334 ALA A 335 -1 O ARG A 334 N ILE A 308 SHEET 1 AA3 2 ILE A 317 LEU A 319 0 SHEET 2 AA3 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA4 6 HIS B 166 SER B 167 0 SHEET 2 AA4 6 LEU B 248 SER B 252 1 O LEU B 249 N HIS B 166 SHEET 3 AA4 6 LEU B 258 VAL B 263 -1 O VAL B 261 N LEU B 249 SHEET 4 AA4 6 THR B 208 LEU B 215 -1 N LYS B 213 O LEU B 260 SHEET 5 AA4 6 GLY B 198 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA4 6 LYS B 191 GLU B 194 -1 N MET B 192 O VAL B 200 SHEET 1 AA5 2 ILE B 317 LEU B 319 0 SHEET 2 AA5 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 SHEET 1 AA6 6 HIS C 166 SER C 167 0 SHEET 2 AA6 6 LEU C 248 SER C 252 1 O LEU C 249 N HIS C 166 SHEET 3 AA6 6 CYS C 259 VAL C 263 -1 O VAL C 261 N LEU C 249 SHEET 4 AA6 6 THR C 208 LEU C 215 -1 N LYS C 213 O LEU C 260 SHEET 5 AA6 6 GLY C 198 VAL C 205 -1 N VAL C 199 O LYS C 214 SHEET 6 AA6 6 LYS C 191 GLY C 193 -1 N MET C 192 O VAL C 200 SHEET 1 AA7 2 ILE C 317 LEU C 319 0 SHEET 2 AA7 2 ALA C 325 ILE C 327 -1 O LYS C 326 N LEU C 318 SHEET 1 AA8 6 HIS D 166 SER D 167 0 SHEET 2 AA8 6 LEU D 248 SER D 252 1 O LEU D 249 N HIS D 166 SHEET 3 AA8 6 CYS D 259 VAL D 263 -1 O VAL D 261 N LEU D 249 SHEET 4 AA8 6 THR D 208 LEU D 215 -1 N LYS D 213 O LEU D 260 SHEET 5 AA8 6 GLY D 198 VAL D 205 -1 N TYR D 201 O VAL D 212 SHEET 6 AA8 6 LYS D 191 GLY D 193 -1 N MET D 192 O VAL D 200 SHEET 1 AA9 2 ILE D 317 LEU D 319 0 SHEET 2 AA9 2 ALA D 325 ILE D 327 -1 O LYS D 326 N LEU D 318 LINK C MET A 344 N TPO A 345 1555 1555 1.35 LINK C TPO A 345 N SEP A 346 1555 1555 1.35 LINK C SEP A 346 N ARG A 347 1555 1555 1.35 LINK C MET B 344 N TPO B 345 1555 1555 1.35 LINK C TPO B 345 N SEP B 346 1555 1555 1.34 LINK C SEP B 346 N ARG B 347 1555 1555 1.34 LINK C MET C 344 N TPO C 345 1555 1555 1.34 LINK C TPO C 345 N SEP C 346 1555 1555 1.34 LINK C SEP C 346 N ARG C 347 1555 1555 1.33 LINK C MET D 344 N TPO D 345 1555 1555 1.35 LINK C TPO D 345 N SEP D 346 1555 1555 1.34 LINK C SEP D 346 N ARG D 347 1555 1555 1.35 CISPEP 1 GLU A 392 PRO A 393 0 1.35 CISPEP 2 GLU B 392 PRO B 393 0 0.39 CISPEP 3 GLU C 392 PRO C 393 0 -0.34 CISPEP 4 GLU D 392 PRO D 393 0 0.49 CRYST1 141.390 139.720 87.270 90.00 123.62 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007073 0.000000 0.004703 0.00000 SCALE2 0.000000 0.007157 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013760 0.00000